Department of Pharmacological Sciences, Università degli Studi di Milano, Centro SISA per lo Studio dell'Aterosclerosi, Ospedale Bassini, Cinisello Balsamo, Milan, Italy.
Curr Opin Lipidol. 2011 Oct;22(5):410-6. doi: 10.1097/MOL.0b013e32834adac3.
HDLs possess several physiological activities that may explain their antiatherosclerotic properties. Among them, the most relevant is the ability of HDL to promote the efflux of excess cholesterol from peripheral tissues to the liver for excretion.
The ability of HDL to promote cholesterol efflux results also in the modulation of a series of responses in the immune cells involved in atherosclerosis, including monocyte-macrophages, B and T lymphocytes. HDL also acts as a reservoir for a number of biologically active substances that may impact the immune system, and as the HDL composition varies to a large extent during inflammation.
The understanding of how these interactions take place and how biologically active substances can be delivered to relevant targets during atherogenesis is of great interest and may provide a better understanding for the role of HDL in atherogenesis.
高密度脂蛋白(HDL)具有多种生理活性,可能解释其抗动脉粥样硬化特性。其中,最相关的是 HDL 促进外周组织中多余胆固醇向肝脏排出的能力。
HDL 促进胆固醇外流的能力还可调节动脉粥样硬化相关免疫细胞(包括单核细胞-巨噬细胞、B 和 T 淋巴细胞)的一系列反应。HDL 还作为许多生物活性物质的储存库,这些物质可能影响免疫系统,并且在炎症过程中 HDL 组成在很大程度上发生变化。
了解这些相互作用是如何发生的,以及在动脉粥样形成过程中生物活性物质如何递送到相关靶标,这非常有意义,并且可能更好地理解 HDL 在动脉粥样形成中的作用。